Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, May 17, 2010
Sun, May 16, 2010 Naked Short Web Site Announces LLEN, HPCCP, ENCO, CBBD, MNAP Have Been Removed From Threshold Lists Friday
May 16, 2010 /M2 PRESSWIRE/ BUYINS.NET, www.buyins.net , announced today that these select companies have been removed from the NASDAQ, AMEX and NYSE naked short threshold lists. L and L Energy (NASDAQ: LLEN), Huntington Preferred Capital (NASDAQ: HPCCP), Encorium Group (NASDAQ: ENCO), China Broadband (OTCBB: CBBD) and Manas Petroleum (OTCBB: MNAP). For a complete list of companies on the naked short lists please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to http://www.buyins.net .
L and L Energy, Inc. (NASDAQ: LLEN), through its subsidiaries, engages in coal mining; clean coal washing; and coal consolidation, coking, and wholesaling businesses in the Peoplea�s Republic of China. The companya�s coal products include raw coal, washed coal, and metallurgical coke. It holds 80% equity interest in the DaPuAn and SuTsong mines, which are located in the Yunnan Province, as well as owns interests in the DaPuAn coal washing facilities. The company distributes its coal through direct sales and third party wholesalers. It was formerly known as L & L International Holdings, Inc. and changed its name to L & L Energy, Inc. on January 4, 2010. The company was founded in 1995 and is headquartered in Seattle, Washington. There is no longer a failure to deliver in shares of LLEN.
Huntington Preferred Capital, Inc. (NASDAQ: HPCCP) operates as a real estate investment trust (REIT) in the United States. It engages in acquiring, holding, and managing mortgage assets and other authorized investments; and investing in real estate assets, which include residential real estate loans and commercial real estate loans, including participation interests in residential or commercial real estate loans and mortgage-backed securities. The companya�s participation interests in commercial real estate loans are secured by real properties, such as office buildings, multi-family properties, family residences, office and industrial condominiums, retail space, strip shopping centers, mixed use commercial properties, mobile home parks, nursing homes, hotels and motels, churches, and farms, as well as industrial, warehouse, and self-storage properties. It also owns participation interests in consumer loans, primarily secured by mortgage on the borrowera�s primary residence for home improvements, acquisition of furniture and fixtures, and debt consolidation, as well as in adjustable rate, fixed rate, conforming, and nonconforming residential real estate loans. The company has elected to be taxed as a REIT under the provisions of the Internal Revenue Code. As a REIT, it would not be subject to federal corporate income taxes, if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 1992 and is based in Columbus, Ohio. There is no longer a failure to deliver in shares of HPCCP.
Encorium Group, Inc. (NASDAQ: ENCO) designs and manages clinical trials for pharmaceutical, biotechnology, and medical device industries primarily in Europe. The companya�s clinical research and development services supporting Phase I through Phase IV clinical trials include data management, such as CRF review and tracking, data entry, clinical/statistical reports, and writing manuscripts for publication; and biostatistics for the use of professionals to develop and review protocols, design analysis plans, and report formats in various phases of drug development. Its services also include strategic trial planning; project management; medical writing; quality assurance and compliance, such as investigator audits, pre-submission protocol compliance audits, and GCP audits; outsourcing clinical staff; and clinical trials management comprising case report form design, investigator recruitment, patient enrollment, and study monitoring and data collection. In addition, Encoriuma�s services include study protocol design; medical and regulatory affairs, such as regulatory strategy formulation, new drug and biologic license application document preparation and review, and quality assurance and liaison; pharmacovigilance; compliance and medical report writing; patient registries; and medical device certification. It also licenses Oracle Clinical and Datafax as its clinical trials management systems. Encorium offers clinical trial services in various therapeutic areas, such as cardiovascular, nephrology, endocrinology/metabolism, hematology, diabetes, neurology, oncology, immunology, vaccines, infectious diseases, gastroenterology, dermatology, hepatology, rheumatology, urology, ophthalmology, womena�s health, and respiratory medicine. It was formerly known as Covalent Group, Inc. and changed its name to Encorium Group, Inc. in October 2006 in connection with the acquisition of Remedium Oy. The company was founded in 1989 and is headquartered in Wayne, Pennsylvania. There is no longer a failure to deliver in shares of ENCO.
China Broadband, Inc. (OTCBB: CBBD) provides cable and wireless broadband services in the Jinan region of China. It principally offers Internet services, Internet protocol point wholesale services, related network equipment rental and sales, and fiber network construction and maintenance services. The company also involves in the print based media and television programming guide publication business in the Shandong Province of China; and the Internet cafe video advertising and content provider business in 29 provinces of China. As of December 31, 2008, it served approximately 58,000 cable broadband subscribers; and a reader base of approximately 250,000 persons. The company is based in Boulder, Colorado. There is no longer a failure to deliver in shares of CBBD.
Manas Petroleum Corporation (OTCBB: MNAP) engages in the exploration and development of oil and gas resources in central Asia, the Balkan Region, and Latin America. The company is based in Baar, Switzerland. There is no longer a failure to deliver in shares of MNAP.
BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.
INVESTMENTS & TRADING
SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 2,750,000,000 short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.
BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Thomas Ronk.
BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.
Contact: Thomas Ronk / CEO www.BUYINS.net (800) 715-9999 tom@buyins.net
- WOPRAI
- support@woprai.com